22/05/2026
We’re delighted to share the recent featured article on 𝘕𝘶𝘵𝘳𝘢𝘐𝘯𝘨𝘳𝘦𝘥𝘪𝘦𝘯𝘵𝘴.𝘤𝘰𝘮, highlighting Sabinsa’s next-generation curcumin innovation, Curcumin C3 Reduct® (May 2026).
This immersive feature, titled ‘𝐍𝐞𝐰 𝐜𝐮𝐫𝐜𝐮𝐦𝐢𝐧 𝐡𝐨𝐫𝐢𝐳𝐨𝐧𝐬: 𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐟𝐨𝐫𝐦𝐚𝐭𝐬,’ explores how Curcumin C3 Reduct® addresses long-standing formulation challenges associated with traditional curcumin, including poor solubility, instability, taste, yellow staining, and limited formulation flexibility.
Building on the strong scientific and clinical legacy of Curcumin C3 Complex®, Curcumin C3 Reduct® represents the next evolution in curcumin innovation, enabling greater formulation flexibility across modern delivery formats.
𝐊𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐂𝐮𝐫𝐜𝐮𝐦𝐢𝐧 𝐂𝟑 𝐑𝐞𝐝𝐮𝐜𝐭®:
● Delivers curcuminoids in their active metabolite form (tetrahydrocurcuminoids – THCs)
● Improves stability and supports enhanced bioavailability potential
● Colorless nature eliminates staining and enables clean-format applications
● Expands usage across beverages, gummies, chewables, oral care, and more
Commenting on this innovation, Dr. Shaheen Majeed (D.Litt.), MBA, Global CEO and MD, Sabinsa, said, "𝘖𝘶𝘳 𝘳𝘰𝘭𝘦 𝘪𝘴 𝘵𝘰 𝘩𝘦𝘭𝘱 𝘣𝘳𝘢𝘯𝘥𝘴 𝘮𝘰𝘷𝘦 𝘧𝘳𝘰𝘮 𝘤𝘰𝘯𝘤𝘦𝘱𝘵 𝘵𝘰 𝘢 𝘧𝘪𝘯𝘪𝘴𝘩𝘦𝘥 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘢𝘴 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵𝘭𝘺 𝘢𝘯𝘥 𝘤𝘰𝘯𝘧𝘪𝘥𝘦𝘯𝘵𝘭𝘺 𝘢𝘴 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦."
Adding to this, Dr. Umar Jan, PhD, MBA, President - European Operations, Sabinsa, said, "𝘛𝘩𝘦 𝘤𝘰𝘭𝘰𝘳𝘭𝘦𝘴𝘴, 𝘵𝘢𝘴𝘵𝘦-𝘯𝘦𝘶𝘵𝘳𝘢𝘭, 𝘱𝘏-𝘴𝘵𝘢𝘣𝘭𝘦 𝘱𝘳𝘰𝘧𝘪𝘭𝘦 𝘰𝘧 𝘊𝘶𝘳𝘤𝘶𝘮𝘪𝘯 𝘊3 𝘙𝘦𝘥𝘶𝘤𝘵® (𝘊3 𝘙𝘦𝘥𝘶𝘤𝘵) 𝘪𝘴 𝘸𝘩𝘢𝘵, 𝘯𝘰𝘸 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘧𝘪𝘳𝘴𝘵 𝘵𝘪𝘮𝘦, 𝘮𝘢𝘬𝘦𝘴 𝘵𝘩𝘦𝘴𝘦 𝘤𝘢𝘵𝘦𝘨𝘰𝘳𝘪𝘦𝘴 𝘨𝘦𝘯𝘶𝘪𝘯𝘦𝘭𝘺 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦 𝘵𝘰 𝘧𝘰𝘳𝘮𝘶𝘭𝘢𝘵𝘰𝘳𝘴 𝘴𝘦𝘦𝘬𝘪𝘯𝘨 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘤𝘶𝘳𝘤𝘶𝘮𝘪𝘯’𝘴 𝘣𝘦𝘯𝘦𝘧𝘪𝘵𝘴 𝘵𝘰 𝘢 𝘣𝘳𝘰𝘢𝘥𝘦𝘳 𝘤𝘰𝘯𝘴𝘶𝘮𝘦𝘳 𝘢𝘶𝘥𝘪𝘦𝘯𝘤𝘦."
As demand grows for science-backed, application-ready ingredients, Sabinsa remains committed to advancing curcumin innovation through research-driven development.
Read more... https://shorturl.at/tEX0q